FOLH1 and neoplasm: At the lowest activity (2 MBq/mouse), the difference in efficacy between [177Lu]Lu-Ibu-DAB-PSMA and [177Lu]Lu-PSMA-ALB-56 was not as obvious as it could have been expected based on the higher calculated absorbed tumor dose for [177Lu]Lu-PSMA-ALB-56.